Literature DB >> 16418985

A prospective trial of a novel, silicone-based, silver-coated foley catheter for the prevention of nosocomial urinary tract infections.

Arjun Srinivasan1, Tobi Karchmer, Ann Richards, Xiaoyan Song, Trish M Perl.   

Abstract

OBJECTIVE: To evaluate the efficacy of silicone-based, silver ion-impregnated urinary catheters in the prevention of nosocomial urinary tract infections (NUTIs).
DESIGN: Prospective, crossover study to compare the efficacy of a silicone-based, hydrogel-coated, silver-impregnated Foley catheter with that of a silicone-based, hydrogel-coated catheter in the prevention of NUTIs.
SETTING: Adult medical and surgical wards of a university teaching hospital.
RESULTS: A total of 3,036 patients with catheters were evaluated; 1,165 (38%) of the catheters were silver impregnated, and 1,871 (62%) were not silver impregnated. Study groups were not identical; there were more men, a shorter duration of catheterization, and fewer urine cultures per 1,000 catheter-days in the silver catheter group. The rate of NUTIs per 1,000 Foley-days was 14.29 in the silver catheter group, compared with 16.15 in the nonsilver catheter group (incidence rate ratio, 0.88; 95% confidence interval, 0.70-1.11; P = .29). The median length of catheterization prior to the onset of a urinary tract infection (ie, exposure time) was 4 days for each group. There were no differences in the recovery of gram-positive, gram-negative, or fungal organisms in NUTIs. In a multivariate survival analysis, no factors, including silver catheters, were protective against NUTI.
CONCLUSIONS: Unlike previous trials of latex-based, silver ion-impregnated Foley catheters, we found that silicone-based, silver-impregnated Foley catheters were not effective in preventing NUTIs; however, this study was affected by differences in the study groups. Prospective trials remain important in assessing the efficacy and cost-effectiveness of new silver-coated products.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16418985     DOI: 10.1086/499998

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  11 in total

1.  Safety and efficacy of a novel silver-impregnated urinary catheter system for preventing catheter-associated bacteriuria: a pilot randomized clinical trial.

Authors:  Anne-Marie Leuck; James R Johnson; Matthew A Hunt; Kush Dhody; Kazem Kazempour; Patricia Ferrieri; Susan Kline
Journal:  Am J Infect Control       Date:  2015-03-01       Impact factor: 2.918

2.  Silver or nitrofurazone impregnation of urinary catheters has a minimal effect on uropathogen adherence.

Authors:  Devak G Desai; Kershena S Liao; Manuel E Cevallos; Barbara W Trautner
Journal:  J Urol       Date:  2010-12       Impact factor: 7.450

3.  Antimicrobial activity Study of triclosan-loaded WBPU on Proteus mirabilis in vitro.

Authors:  Ye Tian; Zhongyu Jian; Jianzhong Wang; Wei He; Qinyu Liu; Kunjie Wang; Hong Li; Hong Tan
Journal:  Int Urol Nephrol       Date:  2017-02-01       Impact factor: 2.370

4.  Prevention and treatment of urinary catheter-associated infections.

Authors:  Mayar Al Mohajer; Rabih O Darouiche
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

Review 5.  New strategies to prevent catheter-associated urinary tract infections.

Authors:  Danish M Siddiq; Rabih O Darouiche
Journal:  Nat Rev Urol       Date:  2012-04-17       Impact factor: 14.432

Review 6.  Use of silver in the prevention and treatment of infections: silver review.

Authors:  Amani D Politano; Kristin T Campbell; Laura H Rosenberger; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2013-02-28       Impact factor: 2.150

Review 7.  Management of catheter-associated urinary tract infection.

Authors:  Barbara W Trautner
Journal:  Curr Opin Infect Dis       Date:  2010-02       Impact factor: 4.915

Review 8.  Metal-Based Nanoparticles for the Treatment of Infectious Diseases.

Authors:  Blessing Atim Aderibigbe
Journal:  Molecules       Date:  2017-08-18       Impact factor: 4.411

Review 9.  Prevention and treatment of biofilms by hybrid- and nanotechnologies.

Authors:  Ramanathan K Kasimanickam; Ashish Ranjan; G V Asokan; Vanmathy R Kasimanickam; John P Kastelic
Journal:  Int J Nanomedicine       Date:  2013-08-02

Review 10.  Catheter associated urinary tract infections.

Authors:  Lindsay E Nicolle
Journal:  Antimicrob Resist Infect Control       Date:  2014-07-25       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.